Practical Tips: Dosage, Timing, and Safety Always start with the manufacturers dosage
Since their approval in 2005, some clinicians have been cautious about prescribing GLP-1 receptor agonists (GLP-1 RAs), or weight loss drugs, to patients with very high triglycerides due to their elevated pancreatitis risk
Not because it is academically interesting, but because it changes which relief strategies actually work for you
The Business Group on Health survey found that among companies that cover GLP-1s for weight management, 10% are unlikely or very unlikely to continue the coverage in 2027 for cost reasons, according to Magda Rusinowski, vice president of the non-profit, which represents employers' perspectives on health-related issues
However, preliminary evidence from phase 3 clinical trials has identified an unexpected safety signal, namely an increased incidence of urinary tract infections